Document is current
Any future updates will be listed below
-
Authors
Lazarus, Jeffrey V. http://orcid.org/0000-0001-9618-2299
White, Trenton M.
Wyka, Katarzyna
Ratzan, Scott C.
Rabin, Kenneth
Larson, Heidi J. http://orcid.org/0000-0002-8477-7583
Martinon-Torres, Federico http://orcid.org/0000-0002-9023-581X
Kuchar, Ernest
Abdool Karim, Salim S. http://orcid.org/0000-0002-4986-2133
Giles-Vernick, Tamara
Müller, Selina http://orcid.org/0000-0003-0886-3487
Batista, Carolina
Myburgh, Nellie
Kampmann, Beate
El-Mohandes, Ayman
- License Information
-
More Information
Article History
Received: 19 December 2023
Accepted: 21 March 2024
First Online: 29 April 2024
Competing interests
: Study funding was provided by Moderna, to the City University of New York Research Foundation. The authors retained full autonomy in the design of the study; the development of the survey instrument; the collection, analysis and interpretation of data; the presentation of results; and the decision to submit the article for publication. J.V.L. has received speaker fees from Echosens, Gilead Sciences, Moderna, Novo Nordisk, Novovax, Pfizer and ViiV and grants from Gilead Sciences, GSK, Madrigal Pharmaceuticals and Roche Diagnostics outside the submitted work. The other authors declare no competing interests.
